Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1993-04-07
1995-08-08
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
A61K 31195
Patent
active
054399386
ABSTRACT:
Methods and devices are taught for regulating penile erection and urethral function. Inhibitors of nitric oxide synthase and precursors of nitric oxide are applied to relax or contract the muscles of the corpus cavernosum and the urethra.
REFERENCES:
patent: 4127118 (1978-11-01), Latorre
patent: 4801587 (1989-01-01), Voss et al.
patent: 4829991 (1989-05-01), Boeck
patent: 5059603 (1992-10-01), Rubin
patent: 5155109 (1992-10-01), Schonafinger et al.
patent: 5187305 (1993-02-01), Thompson et al.
patent: 5225440 (1993-07-01), London et al.
patent: 5242391 (1993-09-01), Place et al.
Burnett, et al., "Nitric Oxide: A Physiologic Mediator of Penile Erection", Science 257:401-403 (1992).
Gillespie et al., "The Effect of Arginine and L-N Monomethyl Arginine on the Response of the Bovine Retractor Penis to Simulation of its NANC Nerves", Br. J. Phar. 97:453P (1989).
Holmquist, et al., "Effects of the Nitric Oxide Synthase Inhibitor N.sup.G -Nitro-L-Arginine on the Erectile Response to Cavernous Nerve Stimulation in the Rabbit", Acta Physiol. Scand. 143:299-304 (1991).
Holmquist, et al., "L-N.sup.G -Nitro Arginine Inhibits Non-Adrenergic, Non-Cholinergic Relaxation of Human Isolated Corpus Cavernosum", Acta Physiol. Scand., 141:441-443 (1991).
Ignarro, et al., "Neurotransmitter Identity Doubt,"Nature, 347:131-132 (1990).
Ignarro, et al. "Nitric Oxide and Cyclic GMP Formation Upon Electrical Field Stimulation Cause Relaxation of Corpus Cavernosum Smooth Muscle," Biochem. Biophys. Res. Comm., 170(2):843-850 (1990).
Kim, et al., "A Nitric Oxide-like Factor Mediates Nonadrenergic-Noncholigenergic Neurogenic Relaxation of Penile Corpus Cavernosum Smooth Muscle," J. Clin. Invest. 88:112-118 (1991).
Pickard, et al., "The Effect of Inhibitors of Nitric Oxide Biosynthesis and Cyclic GMP Formation on Nerve-Evoked Relaxation of Human Cavernosal Smooth Muscle," Br. J. Pharmacol., 104:755-759 (1991).
Rajfer, et al., "Nitric Oxide as a Mediator of Relaxation of the Corpus Cavernosum in Response to Non-Adrenergic, Non-cholinergic Neutrotransmission," New Engl. J. Med., 326(2):90-94 (1992).
Sjostrand, et al., "The Effects of L-arginine and N.sup.G -Monomethyl L-arginine on the Inhibitory Neurotransmission of the Human Corpus Cavernosum Penis," Acta Physiol. Scand., 104:297-298 (1990).
Stroh, "The Root of Importance, Does Nitric Oxide Hold the Key?", Science News, 142(1):10-11 (1992).
Martindale, The Extra Pharmacopoeia, 28th edition (1982) p. 1729.
CRC "Controlled Drug Delivery", vol. II (1983) pp. 73-76.
Bredt David S.
Burnett Arthur L.
Chang Thomas S. K.
Lowenstein Charles J.
Snyder Solomon H.
Henley III Raymond
The Johns Hopkins University
LandOfFree
Treatments for male sexual dysfunction does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatments for male sexual dysfunction, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatments for male sexual dysfunction will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-971611